Amelia A. Langston, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (216 ratings)

Role

Hematology Oncology
Specialty

Leukemia Lymphoma Myeloma and Plasma Cell Disorders Myelodysplastic Syndromes
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1990

Request Appointment

Background

Board certified in internal medicine, hematology and medical oncology, Amelia A. Langston, MD, treats patients with leukemia, myelodysplastic syndrome, lymphoma, graft-versus-host disease (GVHD), aplastic anemia and HIV-related malignancies. Dr. Langston is a practicing physician with Emory Healthcare since 1998.

Titles & Roles

Winship 5K Research Professor and Executive Vice Chair, Department of Hematology and Medical Oncology

Emory University School of Medicine
Director, Bone Marrow and Stem Cell Transplant Program

Winship Cancer Institute of Emory University
Medical Director, Winship Cancer Network

Winship Cancer Institute of Emory University
Executive Vice Chair, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Medical Oncology, 1990
Univ of WA Medical Center
Residency, Internal Medicine, 1987
Duke University Medical Center
Internship, Internal Medicine, 1985
Duke University Medical Center
Medical Education, , 1984
Washington University School of Medicine

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1989
Internal Medicine
American Board of Internal Medicine, 1987

Professional Memberships

American Association for the Advancement of Science
American Society of Hematology

Research

Dr. Langston's research interests include novel strategies for autologous and allogeneic stem cell transplantation, use of biologically targeted agents for antileukemic therapy, and prevention and treatment of opportunistic infections in immunocompromised patients.

View Current Clinical Trials


Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis Phase II Conditions Graft Vs Host Disease Location Winship Cancer Institute
CTL019 Out of Specification MAP for ALL or DLBCL Patients Phase Expanded Access Conditions Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL) Location Winship Cancer Institute

Title/Journal	Authors	Publication Date
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD. Bone marrow transplantation	L Gorfinkel, S Raghunandan, B Watkins, K Hebert, DS Neuberg, B Bratrude, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	01/05/2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for aGVHD Driving Early Transplant Associated Toxicities. Transplantation and cellular therapy	T Takahashi, B Watkins, B Bratrude, D Neuberg, K Hebert, K Betz, A Yu, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, A Langston, LS Kean, M Qayed	06/04/2024
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies. Bone marrow transplantation	S Raghunandan, M Qayed, BK Watkins, M Graiser, L Gorfinkel, A Westbrook, S Gillespie, B Bratrude, A Petrovic, Y Suessmuth, J Horan, LS Kean, AA Langston	01/11/2023
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis. Bone marrow transplantation	S Raghunandan, L Gorfinkel, B Bratrude, Y Suessmuth, K Hebert, D Neuberg, KM Williams, ML Schoettler, AA Langston, LS Kean, M Qayed, J Horan, BK Watkins	01/11/2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood advances	MM Al Malki, K London, J Baez, Y Akahoshi, WJ Hogan, A Etra, H Choe, E Hexner, A Langston, S Abhyankar, DM Ponce, Z DeFilipp, CL Kitko, K Adekola, R Reshef, F Ayuk, A Capellini, C Chanswangphuwana, M Eder, G Eng, I Gandhi, S Grupp, S Gleich, E Holler, NR Javorniczky, S Kasikis, S Kowalyk, G Morales, U Özbek, W Rösler, N Spyrou, G Yanik, R Young, YB Chen, R Nakamura, JLM Ferrara, JE Levine	12/09/2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events. Blood	T Takahashi, M Al-Kofahi, M Jaber, B Bratrude, K Betz, Y Suessmuth, A Yu, DS Neuberg, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, BR Blazar, JT Horan, B Watkins, A Langston, M Qayed, LS Kean	24/08/2023
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. Blood advances	S Raghunandan, L Gorfinkel, M Graiser, B Bratrude, Y Suessmuth, S Gillespie, AL Westbrook, KM Williams, ML Schoettler, LS Kean, J Horan, AA Langston, M Qayed, B Watkins	22/08/2023
Passenger pathogens on physicians. American journal of infection control	CR Funk, S Ravindranathan, A Matelski, H Zhang, C Taylor, S Chandrasekaran, M Arellano, AA Langston, N Joseph, EK Waller	01/07/2023
Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood	A Etra, A Capellini, A Alousi, MM Al Malki, H Choe, Z DeFilipp, WJ Hogan, CL Kitko, F Ayuk, J Baez, I Gandhi, S Kasikis, S Gleich, E Hexner, M Hoepting, U Kapoor, S Kowalyk, D Kwon, A Langston, M Mielcarek, G Morales, U Özbek, M Qayed, R Reshef, W Rösler, N Spyrou, R Young, YB Chen, JLM Ferrara, JE Levine	02/02/2023
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood advances	M Qayed, B Watkins, S Gillespie, B Bratrude, K Betz, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, A Langston, LS Kean, JT Horan	08/02/2022
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Frontiers in immunology	E Stenger, CR Giver, A Langston, D Kota, PK Das, R Chinnadurai, J Galipeau, EK Waller, M Qayed	01/01/2022
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood	C Cutler, SJ Lee, S Arai, M Rotta, B Zoghi, A Lazaryan, A Ramakrishnan, Z DeFilipp, A Salhotra, W Chai-Ho, R Mehta, T Wang, M Arora, I Pusic, A Saad, NN Shah, S Abhyankar, C Bachier, J Galvin, A Im, A Langston, J Liesveld, M Juckett, A Logan, L Schachter, A Alavi, D Howard, HW Waksal, J Ryan, D Eiznhamer, SK Aggarwal, J Ieyoub, O Schueller, L Green, Z Yang, H Krenz, M Jagasia, BR Blazar, S Pavletic	02/12/2021
Cytomegalovirus immunoglobulin G: passive transfer or prior infection? British journal of haematology	M Byrne, AA Langston, GS Booth	01/10/2021
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies. Transplantation and cellular therapy	W Saber, P Steinert, MJ Zhang, M Chen, A Pope, A Keating, JR Wingard, K Ballen, P Stiff, MA Perales, S Forman, R Champlin, A Langston, M Rudebeck, M Horowitz	01/10/2021
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome. Blood advances	AF Herrera, KW Ahn, C Litovich, Y Chen, A Assal, Q Bashir, RL Bayer, M Coleman, Z DeFilipp, N Farhadfar, M Greenwood, T Hahn, M Horwitz, C Jacobson, S Jaglowski, S Lachance, A Langston, B Mattar, RT Maziarz, J McGuirk, MAH Mian, S Nathan, A Phillips, K Rakszawski, H Sengeloev, S Shenoy, R Stuart, CS Sauter, MA Kharfan-Dabaja, M Hamadani	28/09/2021
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, A Yu, S Sinclair, S Furlan, S Bosinger, V Tkachev, J Rhodes, AG Tumlin, A Narayan, K Cribbin, S Gillespie, TA Gooley, MC Pasquini, K Hebert, U Kapoor, A Rogatko, M Tighiouart, S Kim, C Bresee, SW Choi, J Davis, C Duncan, R Giller, M Grimley, AC Harris, D Jacobsohn, N Lalefar, M Norkin, N Farhadfar, MA Pulsipher, S Shenoy, A Petrovic, KR Schultz, GA Yanik, EK Waller, JE Levine, JL Ferrara, BR Blazar, A Langston, JT Horan, LS Kean	10/06/2021
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades. Haematologica	JP Cooper, BE Storer, N Granot, B Gyurkocza, ML Sorror, TR Chauncey, J Shizuru, GN Franke, MB Maris, M Boyer, B Bruno, F Sahebi, AA Langston, P Hari, ED Agura, S Lykke Petersen, RT Maziarz, W Bethge, J Asch, JA Gutman, G Olesen, AM Yeager, K Hübel, WJ Hogan, DG Maloney, M Mielcarek, PJ Martin, MED Flowers, GE Georges, AE Woolfrey, JH Deeg, BL Scott, GB McDonald, R Storb, BM Sandmaier	01/06/2021
Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation. British journal of haematology	GS Booth, BN Savani, AA Langston	01/05/2021
Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia. JCO oncology practice	AP Jillella, ML Arellano, M Gaddh, AA Langston, LT Heffner, EF Winton, ML McLemore, C Zhang, CR Caprara, KS Simon, SL Bolds, S DeBragga, P Karkhanis, SH Krishnamurthy, J Tongol, MM El Geneidy, A Pati, JM Gerber, MR Grunwald, J Cortes, A Bashey, RK Stuart, VK Kota	01/04/2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients. EClinicalMedicine	P Ljungman, A Bermudez, AC Logan, MA Kharfan-Dabaja, P Chevallier, R Martino, G Wulf, D Selleslag, K Kakihana, A Langston, DG Lee, C Solano, S Okamoto, LR Smith, M Boeckh, JR Wingard, B Cywin, C Fredericks, C Lademacher, X Wang, J Young, J Maertens	01/03/2021
Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection. Open forum infectious diseases	AC Sherman, X Lu, E Schneider, A Langston, CL Ellis, S Pastan, J Bhatnagar, S Reagan-Steiner, P Annambhotla, S Lindstrom, A Mehta, SM Pouch, ME Sexton	01/03/2021
Why does the place where the allogeneic transplant patient calls home matter? Cancer	AA Langston	15/02/2021
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8⁺ T cells drive gastrointestinal acute graft-versus-host disease. Science translational medicine	V Tkachev, J Kaminski, EL Potter, SN Furlan, A Yu, DJ Hunt, C McGuckin, H Zheng, L Colonna, U Gerdemann, J Carlson, M Hoffman, J Olvera, C English, A Baldessari, A Panoskaltsis-Mortari, B Watkins, M Qayed, Y Suessmuth, K Betz, B Bratrude, A Langston, JT Horan, J Ordovas-Montanes, AK Shalek, BR Blazar, M Roederer, LS Kean	13/01/2021
Allocating Scarce Health Care Resources During Pandemics: Making the Case for Patients with Advanced and Metastatic Cancer. The oncologist	AA Langston, TE Quest, ER Abernethy, GP Campbell, TK Owonikoko, RD Pentz	01/10/2020
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study. Cancer	JB Cohen, L Wei, KJ Maddocks, B Christian, LT Heffner, AA Langston, MJ Lechowicz, P Porcu, CR Flowers, SM Devine, KA Blum	15/03/2020
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience. Bone marrow transplantation	M Shadman, DG Maloney, B Storer, BM Sandmaier, TR Chauncey, N Smedegaard Andersen, D Niederwieser, J Shizuru, B Bruno, MA Pulsipher, RT Maziarz, ED Agura, P Hari, AA Langston, MB Maris, PA McSweeney, R Storb, ML Sorror	01/01/2020
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports	AP Jillella, ML Arellano, LT Heffner, M Gaddh, AA Langston, HJ Khoury, A Mangaonkar, VK Kota	29/11/2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clinical cancer research : an official journal of the American Association for Cancer Research	HT Kim, KW Ahn, ZH Hu, MS Davids, VO Volpe, JH Antin, ML Sorror, M Shadman, O Press, J Pidala, W Hogan, R Negrin, S Devine, J Uberti, E Agura, R Nash, J Mehta, J McGuirk, S Forman, A Langston, SA Giralt, MA Perales, M Battiwalla, GA Hale, RP Gale, DI Marks, M Hamadani, S Ganguly, U Bacher, H Lazarus, R Reshef, GC Hildebrandt, Y Inamoto, JY Cahn, M Solh, MA Kharfan-Dabaja, N Ghosh, A Saad, M Aljurf, HC Schouten, BT Hill, A Pawarode, T Kindwall-Keller, N Saba, EA Copelan, S Nathan, A Beitinjaneh, BN Savani, J Cerny, MR Grunwald, J Yared, BM Wirk, T Nishihori, S Chhabra, RF Olsson, A Bashey, U Gergis, U Popat, R Sobecks, E Alyea, W Saber, JR Brown	15/08/2019
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. The Lancet. Haematology	BM Sandmaier, B Kornblit, BE Storer, G Olesen, MB Maris, AA Langston, JA Gutman, SL Petersen, TR Chauncey, WA Bethge, MA Pulsipher, AE Woolfrey, M Mielcarek, PJ Martin, FR Appelbaum, MED Flowers, DG Maloney, R Storb	01/08/2019
Acute Myeloid Leukemia in Young Adults: Does Everyone Need a Transplant? Journal of oncology practice	D Roberts MMSc, AA Langston, LT Heffner	01/06/2019
Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis". Journal of thrombosis and haemostasis : JTH	MAT Elsebaie, N Van Es, A Langston, HR Büller, M Gaddh	01/06/2019
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America	GA Papanicolaou, FP Silveira, AA Langston, MR Pereira, RK Avery, M Uknis, A Wijatyk, J Wu, M Boeckh, FM Marty, S Villano	08/04/2019
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH	MAT Elsebaie, N van Es, A Langston, HR Büller, M Gaddh	01/04/2019
Safety and survival outcomes for bloodless transplantation in patients with myeloma. Cancer	NS Joseph, JL Kaufman, LH Boise, K Valla, DK Almaula, CO Obidike, AA Langston, EK Waller, HJ Khoury, CR Flowers, M Graiser, LT Heffner, S Lonial, AK Nooka	15/01/2019
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report. International journal of molecular sciences	CR Funk, CT Petersen, N Jagirdar, S Ravindranathan, DL Jaye, CR Flowers, A Langston, EK Waller	19/12/2018
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RA Taplitz, EB Kennedy, EJ Bow, J Crews, C Gleason, DK Hawley, AA Langston, LJ Nastoupil, M Rajotte, KV Rolston, L Strasfeld, CR Flowers	20/10/2018
Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease. Bone marrow transplantation	HJ Khoury, AA Langston, VK Kota, JA Wilkinson, I Pusic, A Jillella, S Bauer, AS Kim, D Roberts, Z Al-Kadhimi, I Bodo, E Winton, M Arellano, JF DiPersio	01/07/2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	RA Taplitz, EB Kennedy, EJ Bow, J Crews, C Gleason, DK Hawley, AA Langston, LJ Nastoupil, M Rajotte, K Rolston, L Strasfeld, CR Flowers	10/05/2018
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Hosoba, EK Waller, N Shenvi, M Graiser, KA Easley, Z Al-Kadhimi, A Andoh, AG Antun, S Barclay, CD Josephson, JL Koff, HJ Khoury, AA Langston, JC Zimring, JD Roback, CR Giver	01/05/2018
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & lymphoma	V Dhere, S Edelman, EK Waller, A Langston, M Graiser, EC Connolly, JM Switchenko, N Esiashvili, MK Khan	01/04/2018
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer	RM Myers, BT Hill, BE Shaw, S Kim, HR Millard, M Battiwalla, NS Majhail, D Buchbinder, HM Lazarus, BN Savani, MED Flowers, A D'Souza, MJ Ehrhardt, A Langston, JA Yared, RJ Hayashi, A Daly, RF Olsson, Y Inamoto, AK Malone, Z DeFilipp, SP Margossian, AB Warwick, S Jaglowski, A Beitinjaneh, H Fung, KA Kasow, DI Marks, J Reynolds, K Stockerl-Goldstein, B Wirk, WA Wood, M Hamadani, P Satwani	15/02/2018
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports	AP Jillella, ML Arellano, LT Heffner, M Gaddh, AA Langston, HJ Khoury, A Mangoankar, VK Kota	26/09/2017
Opportunity for Collaboration Between Radiation Injury Treatment Network Centers and Medical Toxicology Specialists. Southern medical journal	E Davlantes, S Shartar, J Venero, A Steck, A Langston, ZN Kazzi	01/08/2017
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia? Cancer	JH Kong, EF Winton, LT Heffner, Z Chen, AA Langston, B Hill, M Arellano, F El-Rassi, A Kim, A Jillella, VK Kota, I Bodó, HJ Khoury	01/07/2017
Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma. Clinical lymphoma, myeloma & leukemia	AD Staton, AA Langston	01/07/2017
Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study. Infection control and hospital epidemiology	NN Shah, W McClellan, CR Flowers, S Lonial, H Khoury, EK Waller, A Langston, AK Nooka	01/06/2017
Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period. Transplant infectious disease : an official journal of the Transplantation Society	SD Aldrete, CS Kraft, MJ Magee, A Chan, D Hutcherson, AA Langston, BI Greenwell, EM Burd, R Friedman-Moraco	01/02/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia? Clinical lymphoma, myeloma & leukemia	Z DeFilipp, AA Langston, Z Chen, C Zhang, ML Arellano, F El Rassi, CR Flowers, VK Kota, Z Al-Kadhimi, R Veldman, AP Jillella, S Lonial, EK Waller, HJ Khoury	01/08/2016
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. The Journal of antimicrobial chemotherapy	OA Cornely, RF Duarte, S Haider, P Chandrasekar, D Helfgott, JL Jiménez, A Candoni, I Raad, M Laverdiere, A Langston, N Kartsonis, M Van Iersel, N Connelly, H Waskin	01/03/2016
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	JH Young, BR Logan, J Wu, JR Wingard, DJ Weisdorf, C Mudrick, K Knust, MM Horowitz, DL Confer, ER Dubberke, SA Pergam, FM Marty, LM Strasfeld, JWM Brown, AA Langston, MG Schuster, DR Kaul, SI Martin, C Anasetti	01/02/2016
Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital. Journal of stem cell research & therapy	HD Yun, T Dossul, L Bernal-Mizrachi, J Switchenko, C Ndibe, A Ibraheem, MD Dixon, AA Langston, AK Nooka, CR Flowers, RD Pentz, EK Waller	01/01/2016
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. British journal of haematology	JB Cohen, JM Switchenko, JL Koff, R Sinha, JL Kaufman, HJ Khoury, N Bumpers, A Colbert, A Hutchison-Rzepka, LJ Nastoupil, LT Heffner, AA Langston, MJ Lechowicz, S Lonial, CR Flowers	01/11/2015
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Cancer	JE Vaughn, ML Sorror, BE Storer, TR Chauncey, MA Pulsipher, RT Maziarz, MB Maris, P Hari, GG Laport, GN Franke, ED Agura, AA Langston, AR Rezvani, R Storb, BM Sandmaier, DG Maloney	15/10/2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Transfusion	N Jagirdar, RD Harvey, A Nooka, C Flowers, J Kaufman, S Lonial, MJ Lechowicz, A Langston, C Lipscomb, C Gaylor, EK Waller	01/10/2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia	JB Cohen, S Bucur, EF Winton, R Sinha, LT Heffner, N King, S Lonial, AA Langston, EK Waller, A Hutchison-Rzepka, A Colbert, MJ Lechowicz, CR Flowers	01/09/2015
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood	Y Suessmuth, R Mukherjee, B Watkins, DT Koura, K Finstermeier, C Desmarais, L Stempora, JT Horan, A Langston, M Qayed, HJ Khoury, A Grizzle, JA Cheeseman, JA Conger, J Robertson, A Garrett, AD Kirk, EK Waller, BR Blazar, AK Mehta, HS Robins, LS Kean	18/06/2015
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma. Leukemia & lymphoma	LJ Nastoupil, PJ Shenoy, A Ambinder, JL Koff, AK Nooka, EK Waller, A Langston, M Seward, JL Kaufman, L Bernal-Mizrachi, N King, MJ Lechowicz, S Lonial, R Sinha, CR Flowers	01/02/2015
Dermato-neuro syndrome in a patient treated with autologous stem cell transplant for scleromyxedema. Clinical lymphoma, myeloma & leukemia	SR Shams, DA Goldstein, JL Kaufman, J MacKelfresh, CR Flowers, AA Langston	01/12/2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia. Antimicrobial agents and chemotherapy	RF Duarte, J López-Jiménez, OA Cornely, M Laverdiere, D Helfgott, S Haider, P Chandrasekar, A Langston, J Perfect, L Ma, ML van Iersel, N Connelly, N Kartsonis, H Waskin	01/10/2014
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation. Haematologica	B Kornblit, DG Maloney, BE Storer, MB Maris, L Vindeløv, P Hari, AA Langston, MA Pulsipher, WA Bethge, TR Chauncey, T Lange, FB Petersen, K Hübel, AE Woolfrey, ME Flowers, R Storb, BM Sandmaier	01/10/2014
Incidence and geographic distribution of adult acute leukemia in the state of Georgia. Southern medical journal	F El Rassi, KC Ward, CR Flowers, LT Heffner, EK Waller, EF Winton, J Vaughn, BG Hill, A Langston, A Nooka, M Arellano, HJ Khoury	01/08/2014
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leukemia & lymphoma	Z Mitri, MT Siddiqui, F El Rassi, JT Holden, LT Heffner, A Langston, EK Waller, E Winton, M McLemore, L Bernal-Mizrachi, D Jaye, M Arellano, HJ Khoury	01/07/2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	AK Nooka, HR Johnson, JL Kaufman, CR Flowers, A Langston, C Steuer, M Graiser, Z Ali, NN Shah, S Rangaraju, D Nickleach, J Gao, S Lonial, EK Waller	01/06/2014
Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International journal of radiation oncology, biology, physics	JL Mikell, EK Waller, JM Switchenko, S Rangaraju, Z Ali, M Graiser, WA Hall, AA Langston, N Esiashvili, HJ Khoury, MK Khan	01/06/2014
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series. Clinical lymphoma, myeloma & leukemia	AK Nooka, RD Harvey, A Langston, H Collins, S Lonial, JL Kaufman	01/04/2014
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. Leukemia	AK Nooka, JL Kaufman, S Muppidi, A Langston, LT Heffner, C Gleason, D Casbourne, D Saxe, LH Boise, S Lonial	01/03/2014
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. Bone marrow transplantation	AA Langston, JM Prichard, S Muppidi, A Nooka, MJ Lechowicz, S Lonial, R Sinha, M Graiser, JL Kaufman, HJ Khoury, CR Flowers, EK Waller	01/02/2014
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer	AK Nooka, JL Kaufman, M Behera, A Langston, EK Waller, CR Flowers, C Gleason, LH Boise, S Lonial	01/12/2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma. Clinical lymphoma, myeloma & leukemia	R Sinha, PJ Shenoy, N King, MJ Lechowicz, K Bumpers, D Hutcherson, M Arellano, A Langston, J Kaufman, LT Heffner, EK Waller, A Nooka, CR Flowers, S Lonial	01/12/2013
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	DT Koura, JT Horan, AA Langston, M Qayed, A Mehta, HJ Khoury, RD Harvey, Y Suessmuth, C Couture, J Carr, A Grizzle, HR Johnson, JA Cheeseman, JA Conger, J Robertson, L Stempora, BE Johnson, A Garrett, AD Kirk, CP Larsen, EK Waller, LS Kean	01/11/2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Cancer	AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, F el Rassi, L Bernal-Mizrachi, J Galipeau, LT Heffner, EF Winton, HJ Khoury	01/11/2013
Advances in hematopoietic stem cell transplantation in chronic myeloid leukemia. Discovery medicine	R Veldman, F El Rassi, S Holloway, A Langston, HJ Khoury	01/10/2013
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	RD Harvey, JL Kaufman, HR Johnson, A Nooka, L Vaughn, CR Flowers, HJ Khoury, MJ Lechowicz, AA Langston, S Lonial, EK Waller	01/09/2013
Inherited predisposition to multiple myeloma. Therapeutic advances in hematology	DT Koura, AA Langston	01/08/2013
Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation. Journal of pediatric hematology/oncology	M Qayed, A Langston, KY Chiang, K August, JA Hilinski, CR Cole, A Rogatko, RM Bostick, JT Horan	01/05/2013
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Akhtari, J Kaufman, C Torre, MJ Lechowicz, C Flowers, R Sinha, HJ Khoury, AA Langston, EK Waller	01/03/2013
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	CR Flowers, J Seidenfeld, EJ Bow, C Karten, C Gleason, DK Hawley, NM Kuderer, AA Langston, KA Marr, KV Rolston, SD Ramsey	20/02/2013
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion	JL Kaufman, CR Flowers, KD Rados, GB Calandra, JM Vose, LB Hewes, S Lonial, AA Langston, HJ Khoury, MJ Lechowicz, EK Waller	01/01/2013
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer	M Arellano, S Pakkala, A Langston, M Tighiouart, L Pan, Z Chen, LT Heffner, S Lonial, E Winton, HJ Khoury	01/11/2012
A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias. Cancer	HJ Khoury, G Garcia-Manero, G Borthakur, T Kadia, MC Foudray, M Arellano, A Langston, B Bethelmie-Bryan, S Rush, K Litwiler, S Karan, H Simmons, AI Marcus, M Ptaszynski, H Kantarjian	15/07/2012
High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years. Cancer	M Arellano, E Winton, L Pan, L Lima, M Tighiouart, K Bhalla, LT Heffner, J Neely, D Hutcherson, M McLemore, A Langston, HJ Khoury	15/01/2012
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia	M Arellano, L Bernal-Mizrachi, L Pan, M Tighiouart, L Souza, X Guo, M McLemore, L Lima, S Sunay, LT Heffner, Z Chen, GZ Chen, A Langston, E Winton, HJ Khoury	01/10/2011
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion	J Li, E Hamilton, L Vaughn, M Graiser, H Renfroe, MJ Lechowicz, A Langston, JM Prichard, D Anderson, C Gleason, S Lonial, CR Flowers, JL Kaufman, EK Waller	01/10/2011
A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations. Diagnostic microbiology and infectious disease	E Llata, DB Blossom, HJ Khoury, CY Rao, KA Wannemuehler, J Noble-Wang, AA Langston, BS Ribner, GM Lyon, KE Arnold, DR Jackson, ME Brandt, TM Chiller, SA Balajee, A Srinivasan, SS Magill	01/09/2011
Biomarkers of immune activation to screen for severe, acute GVHD. Bone marrow transplantation	KJ August, KY Chiang, RM Bostick, WD Flanders, EK Waller, A Langston, D Worthington-White, P Rowland, KF Moore, HJ Khoury, JT Horan	01/04/2011
Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond. Cancer	L Lima, L Bernal-Mizrachi, D Saxe, KP Mann, M Tighiouart, M Arellano, L Heffner, M McLemore, A Langston, E Winton, HJ Khoury	15/03/2011
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Transfusion	M Akhtari, CR Giver, Z Ali, CR Flowers, CL Gleason, CD Hillyer, J Kaufman, HJ Khoury, AA Langston, MJ Lechowicz, S Lonial, HM Renfroe, JD Roback, M Tighiouart, L Vaughn, EK Waller	01/11/2010
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study. Clinical cancer research : an official journal of the American Association for Cancer Research	S Lonial, J Kaufman, M Tighiouart, A Nooka, AA Langston, LT Heffner, C Torre, S McMillan, H Renfroe, RD Harvey, MJ Lechowicz, HJ Khoury, CR Flowers, EK Waller	15/10/2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leukemia & lymphoma	H Tran, M Arellano, A Chamsuddin, C Flowers, LT Heffner, A Langston, MJ Lechowicz, A Tindol, E Waller, EF Winton, HJ Khoury	01/08/2010
Use of posaconazole in the treatment of invasive fungal infections. Expert review of hematology	AK Mehta, AA Langston	01/12/2009
Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies. Transplant infectious disease : an official journal of the Transplantation Society	S Murali, A Langston	01/12/2009
Extramedullary acute myeloid leukemia and the use of FDG-PET/CT. Clinical nuclear medicine	S Rao, A Langston, JR Galt, RK Halkar	01/06/2009
Detection of respiratory viruses with a multiplex polymerase chain reaction assay (MultiCode-PLx Respiratory Virus Panel) in patients with hematologic malignancies. Leukemia & lymphoma	S Murali, AA Langston, FS Nolte, G Banks, R Martin, AM Caliendo	01/04/2009
Eosinophilic pulmonary syndrome as a manifestation of GVHD following hematopoietic stem cell transplantation in three patients. Bone marrow transplantation	M Akhtari, AA Langston, EK Waller, AA Gal	01/01/2009
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone marrow transplantation	S Murali, E Winton, EK Waller, LT Heffner, S Lonial, C Flowers, J Kaufman, M Arellano, MJ Lechowicz, KP Mann, HJ Khoury, AA Langston	01/10/2008
Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood	MS Hossain, JD Roback, BP Pollack, DL Jaye, A Langston, EK Waller	15/05/2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion	ML Hicks, S Lonial, A Langston, C Flowers, JD Roback, KJ Smith, S Mossavi Sai, D Teagarden, ES Hamilton, EK Waller, J Kaufman	01/04/2007
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma. Leukemia & lymphoma	S Lonial, M Arellano, D Hutcherson, A Langston, C Flowers, LT Heffner, E Winton, M Jo Lechowicz, EK Waller	01/10/2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer	BT Brinker, EK Waller, T Leong, LT Heffner, I Redei, AA Langston, S Lonial	15/05/2006
A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	S Lonial, M Hicks, H Rosenthal, A Langston, I Redei, C Torre, M Duenzl, B Feinstein, J Cherry, EK Waller	01/12/2004
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood cells, molecules & diseases	EK Waller, CR Giver, H Rosenthal, J Somani, AA Langston, S Lonial, JD Roback, JM Li, MS Hossain, I Redei	01/01/2004
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation	EK Waller, AA Langston, S Lonial, J Cherry, J Somani, AJ Allen, H Rosenthal, I Redei	01/07/2003
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood	AA Langston, I Redei, AM Caliendo, J Somani, D Hutcherson, S Lonial, S Bucur, J Cherry, A Allen, EK Waller	01/02/2002

Awards

Atlanta Magazine "Top Doctors," 2016-2020
James R. Eckman Award for Teaching Excellence, Winship Cancer Institute Fellowship Program, 2007
Alpha Omega Alpha, 1983
American Medical Women's Association Scholarship Achievement Citation, 1984
Lange Medical Publication Award

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.8	One star One star One star One star One half star	Provider discussed treatment options
4.8	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	04/05/2024	Dr. Langston is awesome!
One star One star One star One star One star	26/04/2024	Dr Langston is excellent in all areas.
One star One star One star One star One star	23/04/2024	Dr. Langston has taken excellent care of me since we started the cell stem process.
One star One star One star One star One star	20/04/2024	Educational, Understanding, Inquired about any problems or issues, Great physical evaluation.
One star One star One star One star One star	19/04/2024	I've never met a kinder or more compassionate bunch of people in my entire life as I've been going through my Cancer journey and treatments, as I've met and am being cared for at Winship Cancer Institute. You have the best staff ever and I just wanted to tell you that. They are all Angels.
One star One star One star One star One star	28/03/2024	Excellent doctor!
One star One star One star One star One star	28/03/2024	As usual, I found Dr Langston's care to be both compassionate and thorough. I feel fortunate to have her overseeing my medical needs.
One star One star One star One star One star	21/03/2024	I am very pleased how everyone at the Winship Clinic takes care of me
One star One star One star One star One star	09/02/2024	Dr. Langston is an outstanding physician who clearly knows very well her specialty, treat her patients with empathy and respect. She is an exemplary representative of Emory's cancer center team and the stem cell transplant section.
One star One star One star One star One star	30/01/2024	Dr Langston is the best.
One star One star One star One star One star	20/01/2024	My best visit with Dr. Langston.
One star One star One star One star One star	11/01/2024	Dr Langston is an excellent doctor. I am very happy with her care.
One star One star One star One star One star	29/12/2023	Very caring, professional and knowledgeable regarding my care and consideration.
One star One star One star One star One star	28/11/2023	Very pleased with care provider
One star One star One star One star One star	24/10/2023	Good
One star One star One star One star One star	12/10/2023	Very caring and knowledgeable. I appreciate Dr Langston!
One star One star One star One star One star	10/10/2023	Everyone is always nice and concerned about my care!
One star One star One star One star One half star	05/10/2023	I've always had the best of treatment from the hole staff you're a wonderful cru I love you all Doctors Nurses
One star One star One star One star One star	15/08/2023	Dr Langston was very thorough. Her knowledge is exemplary. Her concerns were for my continued health through the next few years. She was able to provide information that I can continually be on the lookout for.
One star One star One star One star One star	14/08/2023	Care provider is excellent
One star One star One star One star One star	06/08/2023	Dr. Langston is an excellent provider that acts with ethical and superior skill and knowledge.
One star One star One star One star One star	22/07/2023	I really liked Dr. Langston. She explained everything at a level I could understand.
One star One star One star One star One star	29/06/2023	Dr. Langston is a very caring doctor and listens to her patients.
One star One star One star One star One star	29/06/2023	Dr. Langston is the best. I owe her my life.
One star Empty star Empty star Empty star Empty star	08/06/2023	Yesterday was our first time in person meeting our new BMT Dr. Langston. I can say it was awful. She yelled at me when I didn't understand what she was saying. She cut me off several times when talking about the plan. I had to stop her several times and told her I didn't appreciate how she was taking to us. She was not supportive and uplifting very negative. I am worried about our care with her.
One star One star One star One star One star	16/05/2023	We are very happy with Dr. Langston's ongoing care.
One star One star One star One star One star	09/05/2023	Dr. Langston has hung the moon. What a refreshing, thorough explanation of my condition, the progression of my disease, treatment options and recommendations. Answered all my questions, and asked if I had more. If you can, please clone her.
One star One star One star One star One star	26/03/2023	Dr. Langston is a very knowledgeable and caring physician. I feel very fortunate to be under her care.
One star One star One star One star One star	22/03/2023	Dr. Langston was so wonderful! I felt thoroughly informed.
One star One star One star One star One star	02/03/2023	Health care from the best
One star One star One star One star One star	21/02/2023	Dr, Langston, Dr.Goswamy and the entire team were superb
One star One star One star One star One star	09/02/2023	Very impressed with Dr. Langston. Very calm demeanor and was willing to take all the time needed to explain the new drug therapy treatment.
One star One star One star Empty star Empty star	07/02/2023	They didn't care or want to treat me. Sent me back to the horrible care I came from.
One star One star One star One star One star	02/02/2023	I've seen Dr Langston in person wants in Virtual twice. Even with those small short brief visits I still feel I can trust her and I do get the sincere feeling that she is being very upfront with her words and she don't appear to be stressed about my reoccurring questions becauseI forget and/or just don't understand!
One star One star One star One star One star	10/12/2022	Dr. Langston and the etire team is great!
One star One star One star Empty star Empty star	30/08/2022	Everyone seemed to be in such a rush to get done as quickly as possible.
One star One star One star One star One star	04/08/2022	All good
One star One star One star One star One star	28/07/2022	Dr. Langston is an angel. She really cares about her patients. She always seems to have a smile on her face when I visit and it makes me feel relaxed and I feel very optimistic about my health.
One star One star One star One star One star	28/07/2022	Dr. Langston is excellent!
One star One star One star One star One star	16/07/2022	Dr. Langston is outstanding in every way, so glad she is my oncologist.
One star One star One star One star One star	12/07/2022	Dr Langston is the best